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Abstract
Background: Elimination of all animal components during derivation and long-term culture of human embryonic
stem cells (hESCs) is necessary for future applications of hESCs in clinical cell therapy.
Methods: In this study, we established the culture system of xeno-free human foreskin fibroblast feeders (XF-HFF)
in combination with chemically defined medium (CDM). XF-HFF/CDM was compared with several conventional
culture systems. The hESCs cultured in different media were further characterized through karyotype analysis,
pluripotency gene expression, and cell differentiation ability.
Results: The hESCs in the XF-HFF/CDM maintained their characteristics including typical morphology and stable
karyotype. In addition, hESCs were characterized by fluorescent immunostaining of pluripotent markers and
teratoma formation in vivo. RT-PCR analysis shown that the stem cell markers OCT3/4, hTERT, SOX2, and Nanog
were present in the cell line hESC-1 grown on XF-HFF/CDM. Furthermore, the results of cell growth and expression
of bFGF, Oct-4, and hTERT indicated that XF-HFF/CDM had better performance than human serum-matrix/CDM and
XF-HFF/human serum.
Conclusion: The comparison of different xeno-free culture conditions will facilitate clarifying the key features of
self-renewal, pluripotency, and derivation and will shed light on clinic applications of hESCs.
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Background
Human embryonic stem cells (hESCs) can differentiate
into various cell types and possess great potential for cell-
replacement therapy including treatment for diabetes, car-
diac infarction, and neurodegenerative diseases [1, 2]. The
major challenge for the clinical application of hESCs are
animal-derived products and undefined factors during in-
vitro establishment and expansion of the cells. Neverthe-
less, hESCs are conventionally cultured on feeder cell
layers, of which mouse embryonic fibroblasts (MEFs) are
the most common and present several unknown animal-
derived products [3]. The risk of graft rejection and
immunoreactions will be increased greatly, demonstrating
that a xeno-support system sets a limitation for the
therapeutic potential of hESCs to a great extent [4–6].
Optimization and standardization of a fully defined
xeno-free culture for hESCs is therefore urgent.
Xeno-free culture conditions continue to evolve to avoid
exposure to animal-derived materials [7–9]. However, some
issues including chromosomal abnormalities in hESCs arise
due to more demanding growth conditions [10]. On the
contrary, feeder-free cultures generally present a higher de-
gree of spontaneous differentiation in comparison with con-
ventional cultures, signifying that higher concentration of
exogenous basic fibroblast growth factor (bFGF) is required
and feeder-free derivation is not optimal for developing
transplantable hESC derivatives [11].
Considerable progress has been made towards maintain-
ing hESC cultures since human feeder cells were proposed
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[12]. Several researchers have proved the ability to culture
hESCs on human feeder cells which were isolated from
human tissues, including adult marrow tissues [13], fetal
muscle, fetal skin, human placental fibroblasts [14], and
human endometrial cells [15]. Some contributions have
been made to derive and culture new human foreskin
feeders (hFFs) [16–18].
Other groups have attempted to culture hESCs in
chemically defined as well as xeno-free conditions. Some
studies have claimed the defined media can retain hESCs
successfully in their pluripotent state [19, 20], while
other studies have contradicted this [21]. Chin et al. [22]
described the defined StemPro and mTeSR1 media with-
out feeder and the xeno-free HEScGRO medium with
hFFs for hESC growth. Further efforts should be made
to culture hESCs in anticipation of future applications.
In this study, we evaluated whether xeno-free human
foreskin fibroblast feeders (XF-HFF) combined with
chemically defined medium (CDM) could be success-
fully used in long-term maintenance of undifferentiated
hESCs. At the same time, the characteristics of hESCs
grown under these conditions were assessed after pro-
longed culture, including their unlimited and undiffer-
entiated proliferative ability, maintenance of normal
karyotype in long-term culture, and their developmen-
tal potential to differentiate into representative tissues
of all three embryonic germ layers. In addition, the effi-
cacy of this culture system was compared with other
culture conditions with respect to cell growth and un-
differentiated states.
Methods
Human material and ethics statement
The design and performance of this study conformed
to the ethical standards of the Helsinki Declaration and
our national legislation. This study was approved by
the Medical Ethical Committee of The First Affiliated
Hospital, Sun Yat-sen University. An informed consent
form was signed by the participant or the legal guard-
ian for children after receiving a written description of
the study.
Human blood was obtained from healthy donors, in-
fant foreskin from circumcised infants, and discarded
human embryos from donors undergoing clinical in-
vitro fertilization treatment. Patients who donated
blood and foreskins were negative for HIV, hepatitis B
and C, and syphilis.
Preparation of xeno-free human foreskin fibroblast cells
(XF-HFF)
Human serum (HS) and XF-HFF were prepared as de-
scribed previously [1]. XF-HFF were cultured in 90 %
Dulbecco’s modified Eagle’s medium (DMEM; Invitro-
gen, Carlsbad, CA, USA) supplied with 10 % HS, 1 %
penicillin–streptomycin (PS; HyClone Laboratories, Inc.,
Logan, UT, USA). The medium was changed daily. XF-
HFF were normally passaged by TrypLE Select (Invitrogen)
at a 1:8–1:10 split ratio every 3–5 days.
For preparation of feeder layers, XF-HFF were treated
with mitomycin C (Sigma, St. Louis, MO, USA) for 2.5 h,
and the treated cells were reseeded at 75,000 cells/cm2.
Culture media
Four culture systems were described in this study as
follows: XF-HFF combined with CDM (HEScGRO;
Chemicon, Billerica, MA, USA) (XF-HFF/CDM group),
XF-HFF combined with 20 % HS medium (XF-HFF/HS
group), HS-matrix coated on plates without feeder
layers combined with CDM (HS-matrix/CDM group),
and xeno-contained human foreskin fibroblast feeders
(XC-HFF) combined with 20 % KnockOut Serum Re-
placement (KSR medium) (XC-HFF/KSR group). Two
hESC lines (hESC-1, hESC-2) derived in our laboratory
were propagated for 25 passages in the XC-HFF/KSR
group, and were then transferred to the other three
hESC culture systems.
RT-PCR
Total RNA was extracted using the RNeasy kit (Qiagen,
Valencia, CA, USA). Approximately 500 ng of RNA
template was reverse-transcribed into cDNA using the
SuperScript III First-Strand Synthesis System for RT-
PCR (Invitrogen). The cDNA was amplified by PCR
using the Accuprime Taq DNA polymerase system
(Invitrogen). The housekeeping gene glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was used as an
internal positive control. PCR products were run on a
2 % agarose gel, stained with ethidium bromide and
visualized by UV illumination.
The primers sequences were: octamer-binding tran-
scription factor Oct-4, 5′-GAAGGTATTCAGCCAAAC
-3′ and 5′-CTTAATCCAAAAACCCTGG-3′; Nanog,
5′-GATCGGGCCCGCCACCATGAGTGTGGATCCAG
CTTG-3′ and 5′-GATCGAGCTCCATCTTCACACGT
CTTCAGGTTG-3′; human telomerase reverse transcript-
ase (hTERT), 5′-CGGAAGAGTGTCTGGAGCAAGT-3′





Karyotype analysis of hESCs
The genetic stability of hESCs grown in the xeno-free cul-
ture system was determined by examining the karyotype
using a standard G-banding procedure. Briefly, cells were
incubated with colcemid, trypsinized, and then resus-
pended. The samples were then fixed onto the prepared
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slides to make the chromosome spreads. The dried slides
were baked for 90 min at 80 °C, treated with 0.05 % tryp-
sin for 30 sec to 2 min, and then stained with Giemsa and
Leishman’s solution.
Teratoma formation
Teratomas were generated by intramuscular injection of
undifferentiated hESCs (6 × 106 cells) into the hind limb
of severe combined immunodeficient (SCID) mice. The
injected mice were sacrificed at 8 weeks post injection,
and the resulting teratomas were fixed with 4 % parafor-
maldehyde and embedded with paraffin. The samples
were then stained with hematoxylin and eosin, and
observed under a light microscope.
Growth curve analysis
hESCs were plated at a density of 40,000 cells per well
and cultured in different medium. The number of cells
was counted using a hemacytometer at days 3, 5, and 7
to obtain a growth curve.
Flow cytometry
hESC cultures were rinsed with PBS and then incubated
with 0.5 mM EDTA (Sigma) at 37 °C for 5–8 min. The
dissociated cells were rinsed twice in PBS for further
analysis. Single cells were then blocked with 10 % goat
serum (HyClone) for 15 min. All staining procedures
were performed using buffer containing 2 % goat serum,
0.1 % sodium azide (Sigma), and 2 mM EDTA in PBS.
The blocked cells were incubated with primary anti-
bodies (stage-specific embryonic antigen SSEA-4 or
tumor rejection antigen TRA-1-60, 1:20; Chemicon, Te-
mecula, CA) for 30 min at 4 °C followed by three washes
in PBS. The cells were then probed with a 1:100 dilution
of Alexa-488-conjugated goat F(ab′)2 anti-mouse im-
munoglobulin (Ig)G3 or phycoerythrin-conjugated goat
F(ab′)2 anti-mouse IgM (both from Invitrogen) for 30 min
in the dark at 4 °C. The cells were washed once and resus-
pended for analysis in staining buffer containing 1 μg/ml of
propidium iodide (Sigma) to identify nonviable cells. Flow
cytometry analysis was performed using a FACS Calibur
flow cytometer (BD Bioscience, San Jose, CA, USA).
Quantification of Oct-4 and hTERT mRNA
RNA was isolated from hESC populations using an
RNeasy kit (Qiagen), according to the manufacturer’s
protocol. Extracted RNA was subsequently treated with
DNA-free DNase I (Ambion, Austin, TX, USA). Real-time
PCR amplification was performed on an Applied Biosys-
tems International 7500 Sequence Detection System
(Applied Biosystems, Foster City, CA, USA). The TaqMan
one-step RT-PCR master mix (Applied Biosystems) was
applied with the following reaction conditions: RT at 48 °C
for 30 min; denaturation and AmpliTaq gold activation at
95 °C for 10 min; and amplification for 40 cycles at 95 °C
for 15 sec and at 60 °C for 1 min. All reactions were per-
formed in triplicate. The Oct-4 sequences were designed
by Applied Biosystems Primer Express software: forward
primer, 5′-GCA ACC TGG AGA ATT TGT TCC T-3′;
reverse primer, 5′-CCA CAC TCG GAC CAC ATC CT-
3′; and probe, FAM-5′-CAG TGC CCG AAA CCC ACA
CTG C-3′-TAMRA. The 18 s and hTERT probe and
primers were purchased from Applied Biosystems. Rela-
tive quantification of gene expression between multiple
samples was achieved by normalization against endo-
genous18S ribosomal RNA using the △△CT method of
quantification (Applied Biosystems). Relative fold differ-
ence in gene expression was calculated as 2–(ΔΔCT).
Immunofluorescence
The characterization of hESCs grown in animal-free con-
ditions was carried out by measuring the expression of
specific pluripotency markers including: SSEA-3, SSEA-4,
SSEA-1, TRA-1-60, and TRA-1-81. hESCs were washed
once in PBS and fixed in 4 % paraformaldehyde (DGCS
biotech) at room temperature for 15 min. The cells were
then blocked in PBST (PBS containing 0.1 % Triton 100
(DGCS) and 0.25 % normal donkey serum (Jackson
Immuno Research Laboratories, West Baltimore, USA))
at room temperature for 1 h. Primary and secondary
antibodies were diluted in PBST. Cells were incubated
with primary antibodies at 4 °C for 2 h, followed by
three rinses and then incubation with secondary anti-
bodies at room temperature for 1 h. Cells were then
washed three times in PBS prior to imaging. Stained
preparations were examined under a Nikon Eclipse TE-
2000 U fluorescence microscope (Nikon, Tokyo, Japan).
Statistical analysis
All data were obtained from three replicate experi-
ments. Values from all experiments were expressed as
the mean ± standard deviation (SD). Student’s t test and
a chi-square test were employed to analyze the statis-
tical differences between culture groups. The analyses
were performed using SPSS software version 10 (SPSS
Inc., Chicago, IL, USA). p < 0.05 was considered statistically
significant.
Results
Characterizations of hESCs in the XF-HFF/CDM culture
system
hESCs cultured in XF-HFF/CDM exhibit normal cell
morphologies
To determine whether hESCs grown in XF-HFF/CDM
were maintained in an undifferentiated state, the morph-
ology of hESC-1 cultured in XF-HFF/CDM was examined.
As shown in Fig. 1a,b, the hESCs were found to suffer a
series of morphological changes after transferring to the
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new environment. When the undifferentiated colonies
were selected and passaged further, the clones gradually
adapted to the culture system and regained undifferen-
tiated morphology, tightly packed with sharp edges.
The XF-HFF/CDM culture system was able to support
maintenance of undifferentiated hESCs for more than 40
passages. The XF-HFF/CDM culture system can thus
maintain hESCs in an undifferentiated state in the long
term without losing their morphological characteristics.
hESCs cultured in XF-HFF/CDM express stem cell markers
hESCs express stem cell markers that distinguish them
from differentiated cells. To confirm that hESCs grown
in the XF-HFF/CDM are undifferentiated, this was mea-
sured through indirect immunofluorescence staining.
The results showed that hESC-1 grown in XF-HFF/
CDM expressed the expected stem cell markers SSEA-3,
SSEA-4, TRA-1-60, and TRA-1-81 (Fig. 2a). Expression
of OCT3/4, hTERT, SOX2, and Nanog was further verified
by RT-PCR analysis (Fig. 2b). These results indicated that
the exogenous factors in XF-HFF/CDM were sufficient for
hESC growth in an undifferentiated state.
Karyotype of hESCs cultured in XF-HFF/CDM
Because we demonstrated that hESCs cultured in animal-
free XF-HFF/CDM had normal morphological characteris-
tics and expressed stem cell markers, we next determined
whether these hESCs retained a normal chromosome com-
plement because hESCs cultured in vitro may lose their
genetic integrity after several passages. To examine the
genetic stability of hESCs in XF-HFF/CDM, hESC-1 and
hESC-2 cells were karyotyped after >40 passages. The re-
sults showed that the hESCs maintained their normal dip-
loid karyotypes (46 XY and 46 XX, respectively) stably after
more than 40 consecutive passages (Fig. 3a,b). No major
translocations or other chromosomal changes were ob-
served during this period.
hESCs cultured in XF-HFF/CDM are pluripotent
hESCs are pluripotent cells that can differentiate into
the three major cell lineages: endodermal, ectodermal,
and mesodermal. To further describe the differentiation
potential of these hESCs grown in XF-HFF/CDM, we
used teratoma formation to observe which tissues would
develop from these cultures in vivo. Using histochemical
analysis of teratomas after culturing for over 35 passages
in the XF-HFF/CDM conditions, we observed the ap-
pearance of tissues representing all three germ layers –
endoderm (secretory epithelium), ectoderm (skin epithe-
lium), and mesoderm (cartilage) (Fig. 4). These tissues
contained multiple cell types from each of the major cell
lineages. Hence, the cells cultured in XF-HFF/CDM
maintained their pluripotency in vivo.
Comparison of different hESC culture systems
Recently, a xeno-free and feeder-free culture system
based on HS-matrix and CDM or a cofeeder culture sys-
tem based on xeno-free feeder cells and HS medium has
Fig. 1 Morphology of hESC colonies cultured in different conditions. a hESC-1 showed a differentiated state after five passages cultured in XF-
HFF/CDM conditions. b hESC-1 maintained an undifferentiated state cultured in XF-HFF/CDM conditions after 40 passages. c Morphology of
hESC-1 cultured in XF-HFF/HS medium after five passages is elongated with a high nucleus/cytoplasm ratio, but a low propagation rate. d Morphology
of hESC-1 cultured on HS-matrix in CDM medium after five passages is elongated with a low nucleus/cytoplasm ratio and propagation rate.
e Morphology of hESC-1 cells on XC-HFF in KSR medium after 45 passages was still undifferentiated with a high nucleus/cytoplasm ratio
and high propagation rate. Scale bar represents 50 μm
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been developed. To further access their culture efficacy,
the characteristics of hESCs grown in XF-HFF/CDM
were compared with XF-HFF/HS and HS-matrix/CDM.
Two hESC lines were transferred from the original XC-
HFF/KSR culture conditions to other three culture
systems. As shown in Table 1, after transferring four
passages the hESCs in XF-HFF/CDM adapted to the
new environment quickly, and their survival rate was
similar to that in XF-HFF/KSR. Furthermore, the differ-
entiation rate was far lower than that of HS-matrix/
CDM and XF-HFF/HS. These results demonstrate that
it is easier to meet the requirements for hESC growth in
the XF-HFF/CDM system.
Morphology of hESCs cultured with the other three culture
media
Based on morphology, the colonies in XF-HFF/HS and
HS-matrix/CDM became thinner and some lost their
regular shapes and defined borders compared with
that seen in XC-HFF/KSR by bright-field microscopy
(Fig. 1c–e). In the XF-HFF/HS group and the HS-
matrix/CDM group, hESCs lost their undifferentiated
morphology and showed a high rate of differentiation
and a low rate of colony formation (Fig. 1c,d). In
addition, they were unable to maintain their undiffer-
entiated states over six passages. The results indicated
that XF-HFF/CDM had an advantage over XF-HFF/HS
Fig. 2 Expression of stem cell markers in hESC-1 grown on XF-HFF in CDM conditions after >30 passages. a Immunofluorescence staining with
antibodies of stem cell markers: SSEA3 (upper left), SSEA4 (upper left), TRA-1-60 (lower left), and TRA-1-81 (lower right). b RT-PCR analysis of the expression
of stem cell markers OCT3/4, hTERT, SOX2, and Nanog, with GAPDH as positive control. Scale bar represents 50 μm. GAPDH glyceraldehyde-3-
phosphate dehydrogenase, hTERT human telomerase reverse transcriptase, OCT octamer-binding transcription factor, SSEA stage-specific
embryonic antigen, Tra tumor rejection antigen
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and HS-matrix/CDM in maintaining the pluripotency
of hESCs.
Growth of hESCs cultured with the other three culture
media
To further understand the growth rate of hESCs, the cell
number was calculated at days 3, 5, and 7 after transfer-
ring from the initial XC-HFF/KSR condition. As shown in
Fig. 5a, the rate of cell proliferation in XF-HFF/CDM was
obviously higher than that in XF-HFF/HS and HS-matrix/
CDM, which had a similar trend to the growth curve in
XC-HFF/KSR. The analysis verified that XF-HFF/CDM
was superior to HS-matrix/CDM and XF-HFF/HS sys-
tems in supporting the growth of hESCs.
Undifferentiated states of hESC clones under different
culture systems
The undifferentiated states of hESC clones under different
culture systems were compared by analyzing the expression
levels of SSEA-4 and TRA-1-60 by flow cytometry (Fig. 5b).
Consistent with the morphologic observations, both
CDM-cultured and KSR medium-cultured hESC
clones on hFFs expressed high levels of undifferentiated
surface marker expression. hESCs cultured in HS-matrix
with CDM or HS medium on hFFs, however, downregu-
lated these markers.
We also examined the concentrations of bFGF in each
hESC culture medium. After incubation at 37 °C for
24 h, we observed a significant reduction in bFGF levels
in all cultures (p < 0.05), but the reduction was greater in
medium from feeder-free conditions compared with that
in medium from cultures with feeder cells (18.2 % vs
36.8–63.8 %) (Fig. 6a).
We performed quantitative RT (qRT)-PCR to confirm
the expression levels of hESC markers. OCT-4 and
hTERT were expressed in undifferentiated hESCs and
downregulated upon differentiation. Figure 6b shows
that hESCs in HS-matrix conditions or HS medium
Fig. 3 Genetic stability of hESCs cultured in XF-HFF/CDM. Karyotypes of a hESC-1 cells and b hESC-2 cells cultured in XF-HFF/CDM after >40
passages, respectively
Fig. 4 In-vivo analysis of the pluripotency of hESCs cultured in XF-HFF/CDM. hESC-1 cells were s.c. injected into the SCID mice. Sections of the
resulting teratomas were stained with hematoxylin and eosin. Histological analysis of teratomas derived from hESCs cultured in xeno-free conditions
after 35 passages. All three germ-layer-derived tissues were observed, including secretory epithelium (endoderm) (left, 10× magnification), skin
epithelium (ectoderm) (middle, 20× magnification), and cartilage (mesoderm) (right, 20× magnification)
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conditions expressed low levels of OCT-4 and hTERT.
The expression level of the pluripotency marker OCT-4
under XF-HFF/CDM was twofold higher than that under
HS-matrix conditions or HS medium conditions. Meas-
urement of hTERT expression by RT-PCR in four culture
systems showed that the changing trend was almost the
same as that of OCT-4 (Fig. 6b). The hESCs maintained in
the XF-HFF/CDM system therefore had relatively high
levels of OCT-4 and hTERT, resembling undifferentiated
hESCs maintained on XC-HFF/KSR.
Discussion
As a renewable cell source for future regenerative medi-
cine applications, the derivation, passaging, and culture
of hESCs have attracted widespread attention [23]. To
generate therapeutically safe and usable hESC derivatives
for clinical cell treatment, all animal-derived materials
Table 1 Culture efficacy of XF-HFF/CDM conditions and other
culture conditions on the survival and differentiation rates of
hESCs after transferring four passages




XF-HFF/CDM(P25+40) 91.25 ± 2.22 6.00 ± 1.83
HS-matrix/CDM(P25+40) 26.5 ± 2.08* 85.00 ± 3.60*
XF-HFF/HS(P25+40) 77.75 ± 2.21* 86.00 ± 3.37*
XF-HFF/KSR(P25+40) 93.75 ± 2.22 5.50 ± 2.02
aNumber of hESC colonies/total number of hESC colonies
bNumber of hESC colonies with partial or whole differentiation/total number
of hESC colonies
*p < 0.01, control groups versus new culture condition group
CDM chemically-defined medium, hESC human embryonic stem cell, HS human
serum, KSR KnockOut Serum Replacement, XF-HFF xeno-free human foreskin
fibroblast feeders
P25+40, defined as the embryonic stem cells which were established and
cultured in XC-HFF/KSR culture system for 25 passages, then were shifted to
the culture systems of experimental group and control group for 40 passages
Fig. 5 Comparison of different hESC culture systems. a Growth curve of hESCs cultured in four different conditions: 4 × 104 cells from each
culture condition were plated on day 0. Cell numbers were counted from triplicate wells at days 3, 5, and 7 after transferring from the initial XC-HFF/
KSR condition. b Cells cultured in different conditions were analyzed on day 6 by fluorescence-activated cell sorting for SSEA-4 and TRA-1-60. n = 3.
Error bars indicate SD. CDM chemically-defined medium, HS human serum, KSR KnockOut Serum Replacement, SR serum replacement, SSEA
stage-specific embryonic antigen, Tra tumor rejection antigen, XF-HFF xeno-free human foreskin fibroblast feeders
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which are a potential risk for infection transmitted by
animal pathogens must be eliminated during the
process [24].
The major sources of xeno-contamination are the pres-
ence of animal feeders and the use of either FBS or serum
replacement (SR) in the culture medium [4]. Many groups
have previously claimed successful culture of hESCs on
hFFs and other feeders [7, 12, 14, 25–28]. Hovatta et al.
[27] used commercially available human foreskin fibro-
blasts for hESC propagation. Crook et al. [29] proposed
the proof of concept for the generation of six clinical-
grade hESC lines using hFFs as feeder cells. hFFs isolated
from infant foreskin have a distinct advantage over MEFs.
In addition to the xenobiotic issue, hFFs can be cultured
for up to 62 passages before senescence, while MFFs can
only be propagated for five passages [7, 30]. Moreover, lit-
tle ethical concern is considered over the acquirement of
foreskin tissue for the generation of feeder cells.
Another obstacle to overcome was the presence of
FBS or SR in the culture medium. Several studies de-
scribed the use of HS as serum supplement to culture
hESCs. However, it has been proved previously that
commercial xeno-free SRs and human sera are inappro-
priate for long-term culture of hESCs [21]. Some at-
tempts to use HS as a medium supplement failed due
to spontaneous differentiation [12, 26, 31]. It is import-
ant to point out that HS may be involved in the interac-
tions between secreted factors from the feeder cells.
Therefore, it is highly desirable to employ defined compo-
nents rather than complex mixtures [32–35]. The estab-
lishment of a chemically defined xeno-free and feeder-free
culture system is advantageous for exact identification of
factors secreted by feeder layers or signal pathways exist-
ing in them. Thus, xeno-free commercially available CDM
was employed in the culture system.
Our data demonstrate that hESCs can be successfully
derived and cultured long term in the XF-HFF/CDM
system while maintaining their undifferentiated state.
Furthermore, teratoma analysis demonstrated that
hESCs maintain their pluripotency and differentiation
potential, which were comparable with hESCs cultured
in the conventional hESC culture medium. The use of
CDM with hFF cells has been described previously [17].
On the basis of that work, we further presented the dif-
ferences of culture systems for hESCs. We tested four
culture systems and two hESC lines, and little variation
was observed between hESCs cultured in CDM and KSR
medium in maintaining undifferentiated states of hESCs.
On the other hand, data obtained by flow cytometry and
qRT-PCR demonstrated that feeder cells supported the
growth of undifferentiated hESCs more efficiently than
HS-matrix when cells were presented in CDM. The HS-
matrix, which contains hyaluronic acid, fibronectin, and
vitronectin, as well as other unknown human factors,
supports the attachment and growth of undifferentiated
cells [36]. Stojkovic et al. [37] suggested that HS used as
a matrix maintained pluripotency and genomic stability
of hESCs. Meng et al. [38] pointed that extracellular
matrix isolated from foreskin fibroblasts has an advan-
tage in the process of long-term xeno-free hESC culture.
However, feeder-free cultures usually presented a higher
degree of spontaneous differentiation than conventional
Fig. 6 Expression levels of hESC markers under different culture systems. a Concentrations of bFGF in different hESC culture media were
collected after overnight incubation at 4 or 37 °C. b Quantitative RT-PCR TaqMan analysis of Oct-4 and hTERT expression in hESCs maintained in
various conditions. Samples were measured by ELISA for final FGF2 concentrations. Values with SDs are listed below bars in nanograms per
milliliter. n = 3. *p < 0.05, **p < 0.01. Error bars indicate SD. bFGF basic fibroblast growth factor, CDM chemically-defined medium, HS human
serum, hTERT human telomerase reverse transcriptase, KSR KnockOut Serum Replacement, OCT octamer-binding transcription factor, XF-HFF
xeno-free human foreskin fibroblast feeders
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culture along with a higher concentration of exogenous
bFGF, which indicated that feeder-free derivation and
culture were not suitable for developing transplantable
hESC derivatives [11]. The results in this manuscript
also proved that the HS-matrix/CDM system could not
maintain the undifferentiated state and differentiated
potential of hESCs. Although the molecular and devel-
opmental mechanisms controlling the pluripotency and
differentiation of hESCs are largely unknown, feeder
cells may provide a better, more stable environment, and
thus they can secrete the unique proteins that participate
in cell growth, extracellular matrix formation, and re-
modeling [1, 39].
The results demonstrated that CDM provided an effect-
ive replacement for HS medium, comparable with KSR
medium, to support hESC self-renewal and pluripotency.
This observation suggests that CDM and KSR medium
culture conditions supply similar growth factors or signal
pathways for hESC growth. CDM is more suitable than
serum-containing medium for studies that aimed at iden-
tifying the exogenous signals required for undifferentiated
hESC growth. XF-HFF/HS were unable to maintain undif-
ferentiated of hESCs in long-term growth.
Exogenous bFGF has been identified as a key factor
involved in self-renewal of hESCs [40–43], and some
studies have indicated that FGF proteins are sensitive
to thermal denaturation, while fibroblasts likely secrete
either protease inhibitors or binding proteins that modu-
late bFGF stability [42, 44]. In our work, we found that
bFGF was unstable in 37 °C culture conditions. Although
the concentrations of bFGF declined in all culture condi-
tions, they were higher in cofeeder conditions than in
feeder-free conditions. The data indicated that fibro-
blast is likely to secrete some proteins which modulate
the stability of bFGF [42], and also indicated that the
stability of bFGF was not the only factor responsible for
the successful culture of hESCs.
Lysophosphatidic acid (LPA) as the key lipid is a sim-
ple phospholipid mediator which plays an important
role in the regulation of cell proliferation, migration,
and survival of multiple cell types [45, 46]. Todorova et
al. [47] proposed that LPA was involved in the
expression of the Ca2+-dependent early response gene
c-myc, which was a key gene implicated in ESC self-
renewal and pluripotency. Therefore, LPA increased the
proliferation rate of mESCs. Liu et al. demonstrated
that LPA induced the expression of the erythroid bio-
markers in cultured human hematopoietic stem cells
(hHSCs) under plasma-free conditions. In addition,
LPA was also reported to enhance osteogenic differenti-
ation of human mesenchymal stem cells [48]. These
results suggested that LPA may play a critical role in cell
fate determination. Hence, we suspected that HFF-1 cells
could secrete LPA to support the long-term culture.
Conclusion
We have reported the development of a xeno-free and
serum-free method for culturing hESCs. The hESCs in the
established XF-HFF/CDM culture system maintained
their properties, such as typical morphology, pluripotency,
capacity to form three germ layers in vivo, and stable
karyotype. The results show that the XF-HFF/CDM
culture medium is applicable for further optimization of
xeno-free establishment, culture, and differentiation of
stem cells. Future studies should focus on the comparison
of different xeno-free culture conditions and on validation
of these conditions to demonstrate the key features of
self-renewal, pluripotency, and derivation.
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